Deferoxamine in Stroke Patients - A study to Evaluate the Safety and Tolerability of the Iron Chelator, Deferoxamine

Suspended

Phase N/A Results N/A

Summary of Purpose

To evaluate the safety of deferoxamine treatment in acute stroke patients over 50 years old without known iron overload; and to examine its effects on biological markers of oxidative stress.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 June 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Investigator-initiated, prospective, open-label, single-center, single-arm, pilot clinical study.

Contacts

Not available